152 related articles for article (PubMed ID: 36697096)
1. Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks.
Koyi H; Wilander E
Anticancer Res; 2023 Feb; 43(2):669-673. PubMed ID: 36697096
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Utility of Claudin4 and Comparison with BerEp4 as a Marker for Metastatic Adenocarcinoma in Serous Effusions.
Mangla G; Bakshi P; Agarwal P; Verma K
Acta Cytol; 2023; 67(5):564-572. PubMed ID: 37331346
[TBL] [Abstract][Full Text] [Related]
3. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
[TBL] [Abstract][Full Text] [Related]
4. P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
Stoetzer OJ; Munker R; Darsow M; Wilmanns W
Oncol Rep; 1999; 6(2):455-8. PubMed ID: 10023021
[TBL] [Abstract][Full Text] [Related]
5. Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: an immunocytochemical study.
Athanassiadou P; Gonidi M; Liossi A; Petrakakou E; Nakopoulou L; Zerva C; Athanassiades P
Pathol Oncol Res; 2000; 6(2):100-3. PubMed ID: 10936783
[TBL] [Abstract][Full Text] [Related]
6. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
7. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
8. Quality of cell blocks prepared from residual pleural effusion and bronchial washing samples for immunocytochemistry.
Harabajsa S; Milutin L; Breški A; Ražnjević K; Šimić V; Branica BV; Smojver-Ježek S
Cytopathology; 2023 May; 34(3):264-270. PubMed ID: 36941745
[TBL] [Abstract][Full Text] [Related]
9. [The immunocytochemical study of pleural effusion and ascites using Ber-EP-4 antibodies].
Spehn J; Iwanetz S; Schmitz-Huebner U
Dtsch Med Wochenschr; 1995 Sep; 120(36):1197-200. PubMed ID: 7671771
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4.
De Angelis M; Buley ID; Heryet A; Gray W
Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160
[TBL] [Abstract][Full Text] [Related]
11. Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology.
Gulyas M; Fillinger J; Kaposi AD; Molnar M
J Clin Pathol; 2019 Aug; 72(8):529-535. PubMed ID: 31028099
[TBL] [Abstract][Full Text] [Related]
12. Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry.
Liao ND; Lee WY
Cancer Cytopathol; 2012 Aug; 120(4):269-75. PubMed ID: 22367930
[TBL] [Abstract][Full Text] [Related]
13. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.
Bailey ME; Brown RW; Mody DR; Cagle P; Ramzy I
Acta Cytol; 1996; 40(6):1212-6. PubMed ID: 8960030
[TBL] [Abstract][Full Text] [Related]
14. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions.
Hafez NH; Tahoun NS
J Egypt Natl Canc Inst; 2011 Dec; 23(4):155-62. PubMed ID: 22776843
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies in the cytodiagnosis of serous effusions.
al-Nafussi A; Carder PJ
Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
[TBL] [Abstract][Full Text] [Related]
20. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]